The U.S. public increasingly embraces the legalization and implementation of psychedelic drugs for medical treatments. Read More
Analyst Articles
Both the economy and inflation are cooling, but not to such an extent that fears of a deep recession are warranted. Read More
As developing nations regain momentum, Vietnam is a resource-rich land with underappreciated appeal for investors. Read More
With all the attention paid to marijuana, investors are giving short shrift to hemp. This plant is an under-the-radar opportunity. Read More
The U.S. mega-banks are expected to post weak Q1 operating results and grim outlooks for the rest of 2023. Equities hang in the balance. Read More
It's Wall Street's dirty secret: the crystal ball gazers who make long-term forecasts have a terrible track record. Read More
In correspondence with readers, our editorial director answers questions about asset bubbles, portfolio hedges, and options trading for accelerated income. Read More
High-yielding stocks are appealing, but if their yields aren’t sustainable, you could get caught in a trap. Take these preventive steps. Read More
After an upbeat first quarter, the month of April has heralded unpleasant surprises and renewed recession fears. Read More
Opportunities are plentiful in the cannabis sector, but so are predators. Looking to buy pot stocks? Here's how to avoid getting slaughtered. Read More